Terms: = Pancreatic cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Prognosis
5 results:
1. Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer.
Prajapati DR; Molczyk C; Purohit A; Saxena S; Sturgeon R; Dave BJ; Kumar S; Batra SK; Singh RK
Cancer Lett; 2023 Jun; 563():216185. PubMed ID: 37062329
[TBL] [Abstract] [Full Text] [Related]
2. β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway.
Gong C; Hu B; Chen H; Zhu J; Nie J; Hua L; Chen L; Fang Y; Hang C; Lu Y
J Mol Histol; 2022 Aug; 53(4):645-655. PubMed ID: 35717490
[TBL] [Abstract] [Full Text] [Related]
3. Chk1 inhibitor sch 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer.
Li JA; Song C; Rong Y; Kuang T; Wang D; Xu X; Yuan J; Luo K; Qin B; Nowsheen S; Lou Z; Lou W
Cell Cycle; 2018; 17(2):191-199. PubMed ID: 29157102
[TBL] [Abstract] [Full Text] [Related]
4. The expression and phosphorylation of ezrin and merlin in human pancreatic cancer.
Zhou J; Feng Y; Tao K; Su Z; Yu X; Zheng J; Zhang L; Yang D
Int J Oncol; 2014 Jun; 44(6):2059-67. PubMed ID: 24728215
[TBL] [Abstract] [Full Text] [Related]
5. Function and cancer genomics of FAT family genes (review).
Katoh M
Int J Oncol; 2012 Dec; 41(6):1913-8. PubMed ID: 23076869
[TBL] [Abstract] [Full Text] [Related]
